Placebo-controlled study evaluating efficacy and safety of Onartuzumab (MetMab) in combination with 5-Fluorouracil, folinic acid and oxaliplatin (mFOLFOX6) in patients with Her2-negative

Project: Research

StatusFinished
Effective start/end date29/04/1330/06/15